In other countries
The same active substances on other registers, the same brand first.
- KisunlaBrazil · Eli Lilly do Brasil LtdaSame brand
- KisunlaCanada · 17.5 MG / ML · Solution · Eli Lilly Canada INCSame brand
- Kisunla 350 MG Concentrado Para Solucion Para PerfusionSpain · 350 mg · concentrado para solución para perfusión · Eli Lilly Nederland B.V.Same brand
- KisunlaEuropean Union · Eli Lilly Nederland B.V.Same brand
- KisunlaItaly · Concentrato per soluzione per infusione · Eli Lilly Nederland B.V.Same brand
- Kisunla 350 mg concentraat voor oplossing voor infusieNetherlands · Concentraat voor oplossing voor infusie · Eli Lilly Nederland B.V.Same brand
- KisunlaUnited States · 350MG/20ML · injectable · Eli Lilly CoSame brand
- Lormalzi Concentrate for Solution for Infusion 350mg/20mLSingapore · 350mg/20mL · infusion, solution concentrate · DKSH Singapore Pte. LTD.Same substance
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
HALMED — Agencija za lijekove i medicinske proizvode RH
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence: Otvorena dozvola RH NN 67/2017 · Added 8 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substance
- Donanemab
- Register
- Croatia (HALMED)
- Status
- Authorised
- Registration
- 17890
- ATC code
- N06DX05
- Group
- Nervous system
- Procedure
- EU centralised
- Supply
- na recept; u ljekarni